Sanofi | SNY - Stock




Sanofi reported 10.61B in Stock for its fiscal quarter ending in June of 2024.

Stock Change Date
AbbVie USD 4.45B 232M Sep/2024
Amgen USD 7B 364M Dec/2024
AstraZeneca USD 5.29B 374M Dec/2024
Bristol-Myers Squibb USD 2.56B 775M Dec/2024
Canopy Growth CAD 90.09M 5.58M Sep/2024
Corcept Therapeutics USD 8.05M 300K Sep/2024
Drreddys Laboratories 68.57B 5.02B Jun/2024
Eli Lilly USD 7.46B 978.3M Sep/2024
Galapagos EUR 51.19M 14.37M Dec/2024
Genmab DKK 62M 9M Dec/2024
GlaxoSmithKline GBP 5.67B 249M Dec/2024
Glaxosmithkline 5.92B 216M Sep/2024
Indivior 178M 64M Sep/2024
J&J USD 12.6B 434M Sep/2024
Merck USD 6.24B 225M Sep/2024
Novartis USD 5.72B 216M Dec/2024
Novartis USD 5.94B 727M Sep/2024
Pacira USD 111.86M 8.42M Sep/2024
Perrigo USD 1.13B 17.6M Sep/2024
Pfizer USD 11.72B 274M Sep/2024
Prestige Brands USD 151.52M 4.71M Dec/2024
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 10.61B 943M Jun/2024
Sanofi 10.61B 943M Jun/2024
Supernus Pharmaceuticals USD 63.98M 4.17M Sep/2024
UCB 1.14B 105M Jun/2024
Zoetis USD 2.31B 110M Dec/2024